Casein kinase 1δ-IN-8
Casein kinase 1δ-IN-8 (compound 494) is an inhibitor of Casein kinase 1δ, Casein kinase 1δ-IN-8 can be used in the treatment of neurodegenerative disorders such as Alzheimer's disease[1].
Product Specifications
CAS Number
[851396-73-1]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Casein Kinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Stem Cell/Wnt
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/casein-kinase-1δ-in-8.html
Purity
98.0
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(CSC1=NN=C(N1C2=CC=C(C=C2)F)C3=CC=NC=C3)C4=CC=CN4
Molecular Formula
C19H14FN5OS
Molecular Weight
379.41
Precautions
H302, H315, H319
References & Citations
[1]Sheridan, Joseph M, et, al. Casein kinase 1δ inhibitors for the treatment of neurodegenerative disorders. WO2012080729 A2 2012-06-21.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Lipoprotein signal peptidase (lspA)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Lipoprotein signal peptidase (lspA)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Lipoprotein signal peptidase (lspA)
Proteinase 3 (Proteinase-3, PR3, PR-3, PRTN3, ACPA, Azurophil Granule Protein 7, AGP7, cANCA, c-ANCA Antigen, EC 3.4.21.76, Leukocyte Proteinase 3, MBT, Myeloblastin, MBN, Neutrophil Proteinase 4, NP4, NP-4, p29, Wegener Autoantigen) (APC) discontinued